nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A2—Vinblastine—head and neck cancer	0.145	0.255	CbGbCtD
Desipramine—CYP2A6—Fluorouracil—head and neck cancer	0.125	0.219	CbGbCtD
Desipramine—CYP2D6—Hydroxyurea—head and neck cancer	0.103	0.181	CbGbCtD
Desipramine—CYP1A2—Fluorouracil—head and neck cancer	0.0477	0.0837	CbGbCtD
Desipramine—ABCB1—Vinblastine—head and neck cancer	0.0386	0.0678	CbGbCtD
Desipramine—CYP2D6—Vinblastine—head and neck cancer	0.0364	0.0639	CbGbCtD
Desipramine—ABCB1—Docetaxel—head and neck cancer	0.0318	0.0559	CbGbCtD
Desipramine—CYP3A4—Vinblastine—head and neck cancer	0.0231	0.0406	CbGbCtD
Desipramine—SLC22A4—glottis—head and neck cancer	0.0191	0.184	CbGeAlD
Desipramine—CYP3A4—Docetaxel—head and neck cancer	0.0191	0.0335	CbGbCtD
Desipramine—Ileus paralytic—Vinblastine—head and neck cancer	0.00812	0.046	CcSEcCtD
Desipramine—SLC22A4—larynx—head and neck cancer	0.00675	0.0651	CbGeAlD
Desipramine—HRH1—nose—head and neck cancer	0.00624	0.0602	CbGeAlD
Desipramine—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.00604	0.0342	CcSEcCtD
Desipramine—ORM1—saliva—head and neck cancer	0.00575	0.0555	CbGeAlD
Desipramine—Drug fever—Docetaxel—head and neck cancer	0.00499	0.0282	CcSEcCtD
Desipramine—Sudden death—Fluorouracil—head and neck cancer	0.00451	0.0255	CcSEcCtD
Desipramine—Numbness—Vinblastine—head and neck cancer	0.00424	0.024	CcSEcCtD
Desipramine—HTR2A—trigeminal nerve—head and neck cancer	0.00409	0.0394	CbGeAlD
Desipramine—Sensory loss—Vinblastine—head and neck cancer	0.00405	0.023	CcSEcCtD
Desipramine—Raised liver function tests—Docetaxel—head and neck cancer	0.0036	0.0204	CcSEcCtD
Desipramine—HTR2A—cranial nerve—head and neck cancer	0.00291	0.0281	CbGeAlD
Desipramine—Tingling sensation—Fluorouracil—head and neck cancer	0.00287	0.0162	CcSEcCtD
Desipramine—SLC22A3—tongue—head and neck cancer	0.00283	0.0273	CbGeAlD
Desipramine—Numbness—Fluorouracil—head and neck cancer	0.00278	0.0157	CcSEcCtD
Desipramine—SMPD1—connective tissue—head and neck cancer	0.00272	0.0263	CbGeAlD
Desipramine—Sensory loss—Fluorouracil—head and neck cancer	0.00266	0.0151	CcSEcCtD
Desipramine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0026	0.0147	CcSEcCtD
Desipramine—Disorientation—Hydroxyurea—head and neck cancer	0.0026	0.0147	CcSEcCtD
Desipramine—CHRM3—exocrine gland—head and neck cancer	0.00221	0.0213	CbGeAlD
Desipramine—SMPD1—lymphoid tissue—head and neck cancer	0.00199	0.0192	CbGeAlD
Desipramine—Depression—Vinblastine—head and neck cancer	0.00196	0.0111	CcSEcCtD
Desipramine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00194	0.011	CcSEcCtD
Desipramine—Myocardial infarction—Vinblastine—head and neck cancer	0.00193	0.0109	CcSEcCtD
Desipramine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00193	0.0109	CcSEcCtD
Desipramine—SLC22A3—mouth—head and neck cancer	0.0019	0.0184	CbGeAlD
Desipramine—Disorientation—Fluorouracil—head and neck cancer	0.00187	0.0106	CcSEcCtD
Desipramine—Agranulocytosis—Vinblastine—head and neck cancer	0.00183	0.0104	CcSEcCtD
Desipramine—Weight increased—Hydroxyurea—head and neck cancer	0.00183	0.0104	CcSEcCtD
Desipramine—SMPD1—thyroid gland—head and neck cancer	0.00181	0.0174	CbGeAlD
Desipramine—Drowsiness—Hydroxyurea—head and neck cancer	0.00179	0.0101	CcSEcCtD
Desipramine—SLC22A4—neck—head and neck cancer	0.00179	0.0173	CbGeAlD
Desipramine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00176	0.00994	CcSEcCtD
Desipramine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00175	0.00994	CcSEcCtD
Desipramine—Stomatitis—Hydroxyurea—head and neck cancer	0.00175	0.00989	CcSEcCtD
Desipramine—CHRM5—epithelium—head and neck cancer	0.00172	0.0166	CbGeAlD
Desipramine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00166	0.00942	CcSEcCtD
Desipramine—SMPD1—head—head and neck cancer	0.0016	0.0155	CbGeAlD
Desipramine—Hallucination—Hydroxyurea—head and neck cancer	0.0016	0.00906	CcSEcCtD
Desipramine—Ataxia—Fluorouracil—head and neck cancer	0.00157	0.00891	CcSEcCtD
Desipramine—Alopecia—Vinblastine—head and neck cancer	0.00156	0.00882	CcSEcCtD
Desipramine—Lightheadedness—Docetaxel—head and neck cancer	0.00149	0.00843	CcSEcCtD
Desipramine—Eosinophilia—Fluorouracil—head and neck cancer	0.00143	0.00811	CcSEcCtD
Desipramine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00142	0.00807	CcSEcCtD
Desipramine—Alopecia—Hydroxyurea—head and neck cancer	0.00142	0.00805	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00139	0.00786	CcSEcCtD
Desipramine—Malaise—Vinblastine—head and neck cancer	0.00138	0.00784	CcSEcCtD
Desipramine—CHRM4—head—head and neck cancer	0.00137	0.0132	CbGeAlD
Desipramine—Convulsion—Vinblastine—head and neck cancer	0.00133	0.00753	CcSEcCtD
Desipramine—SLC22A3—parotid gland—head and neck cancer	0.00133	0.0128	CbGeAlD
Desipramine—Hypertension—Vinblastine—head and neck cancer	0.00133	0.0075	CcSEcCtD
Desipramine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0013	0.00736	CcSEcCtD
Desipramine—Discomfort—Vinblastine—head and neck cancer	0.00129	0.00731	CcSEcCtD
Desipramine—CHRM1—parotid gland—head and neck cancer	0.00129	0.0124	CbGeAlD
Desipramine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00127	0.0072	CcSEcCtD
Desipramine—SLC22A3—saliva-secreting gland—head and neck cancer	0.00127	0.0123	CbGeAlD
Desipramine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00126	0.00716	CcSEcCtD
Desipramine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00126	0.00716	CcSEcCtD
Desipramine—Malaise—Hydroxyurea—head and neck cancer	0.00126	0.00715	CcSEcCtD
Desipramine—Stomatitis—Fluorouracil—head and neck cancer	0.00126	0.00712	CcSEcCtD
Desipramine—CHRM1—saliva-secreting gland—head and neck cancer	0.00123	0.0119	CbGeAlD
Desipramine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00123	0.00695	CcSEcCtD
Desipramine—Convulsion—Hydroxyurea—head and neck cancer	0.00121	0.00687	CcSEcCtD
Desipramine—Agranulocytosis—Fluorouracil—head and neck cancer	0.0012	0.00681	CcSEcCtD
Desipramine—Anorexia—Vinblastine—head and neck cancer	0.00119	0.00676	CcSEcCtD
Desipramine—Discomfort—Hydroxyurea—head and neck cancer	0.00118	0.00667	CcSEcCtD
Desipramine—ADRB1—connective tissue—head and neck cancer	0.00118	0.0113	CbGeAlD
Desipramine—SLC22A3—connective tissue—head and neck cancer	0.00117	0.0113	CbGeAlD
Desipramine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00115	0.00652	CcSEcCtD
Desipramine—Oedema—Hydroxyurea—head and neck cancer	0.00114	0.00647	CcSEcCtD
Desipramine—Ataxia—Docetaxel—head and neck cancer	0.00114	0.00643	CcSEcCtD
Desipramine—Paraesthesia—Vinblastine—head and neck cancer	0.00113	0.00637	CcSEcCtD
Desipramine—SMPD1—lymph node—head and neck cancer	0.00112	0.0108	CbGeAlD
Desipramine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00112	0.00633	CcSEcCtD
Desipramine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00112	0.00631	CcSEcCtD
Desipramine—CHRM3—saliva-secreting gland—head and neck cancer	0.0011	0.0106	CbGeAlD
Desipramine—Anorexia—Hydroxyurea—head and neck cancer	0.00109	0.00617	CcSEcCtD
Desipramine—Decreased appetite—Vinblastine—head and neck cancer	0.00109	0.00617	CcSEcCtD
Desipramine—SLC22A4—trachea—head and neck cancer	0.00108	0.0104	CbGeAlD
Desipramine—Constipation—Vinblastine—head and neck cancer	0.00107	0.00607	CcSEcCtD
Desipramine—CHRM5—head—head and neck cancer	0.00107	0.0103	CbGeAlD
Desipramine—Arrhythmia—Fluorouracil—head and neck cancer	0.00103	0.00586	CcSEcCtD
Desipramine—Feeling abnormal—Vinblastine—head and neck cancer	0.00103	0.00585	CcSEcCtD
Desipramine—Alopecia—Fluorouracil—head and neck cancer	0.00102	0.00579	CcSEcCtD
Desipramine—Somnolence—Hydroxyurea—head and neck cancer	0.00102	0.00575	CcSEcCtD
Desipramine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00101	0.0057	CcSEcCtD
Desipramine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000993	0.00562	CcSEcCtD
Desipramine—Abdominal pain—Vinblastine—head and neck cancer	0.000991	0.00561	CcSEcCtD
Desipramine—Fatigue—Hydroxyurea—head and neck cancer	0.000985	0.00558	CcSEcCtD
Desipramine—Constipation—Hydroxyurea—head and neck cancer	0.000977	0.00553	CcSEcCtD
Desipramine—SLC22A5—parotid gland—head and neck cancer	0.000964	0.0093	CbGeAlD
Desipramine—Weight increased—Docetaxel—head and neck cancer	0.00095	0.00538	CcSEcCtD
Desipramine—CHRM1—trachea—head and neck cancer	0.00095	0.00916	CbGeAlD
Desipramine—Vision blurred—Fluorouracil—head and neck cancer	0.00095	0.00538	CcSEcCtD
Desipramine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000942	0.00533	CcSEcCtD
Desipramine—SLC22A5—saliva-secreting gland—head and neck cancer	0.000924	0.00891	CbGeAlD
Desipramine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000918	0.0052	CcSEcCtD
Desipramine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000912	0.00517	CcSEcCtD
Desipramine—Myocardial infarction—Docetaxel—head and neck cancer	0.000912	0.00517	CcSEcCtD
Desipramine—Jaundice—Docetaxel—head and neck cancer	0.000907	0.00514	CcSEcCtD
Desipramine—Stomatitis—Docetaxel—head and neck cancer	0.000907	0.00514	CcSEcCtD
Desipramine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000903	0.00511	CcSEcCtD
Desipramine—Asthenia—Vinblastine—head and neck cancer	0.000899	0.00509	CcSEcCtD
Desipramine—Convulsion—Fluorouracil—head and neck cancer	0.000873	0.00494	CcSEcCtD
Desipramine—Agranulocytosis—Docetaxel—head and neck cancer	0.000869	0.00492	CcSEcCtD
Desipramine—Diarrhoea—Vinblastine—head and neck cancer	0.000857	0.00485	CcSEcCtD
Desipramine—SLC22A4—thyroid gland—head and neck cancer	0.000852	0.00822	CbGeAlD
Desipramine—Discomfort—Fluorouracil—head and neck cancer	0.000848	0.0048	CcSEcCtD
Desipramine—HTR2A—neck—head and neck cancer	0.000839	0.00809	CbGeAlD
Desipramine—Hepatitis—Docetaxel—head and neck cancer	0.000836	0.00473	CcSEcCtD
Desipramine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000831	0.00471	CcSEcCtD
Desipramine—Confusional state—Fluorouracil—head and neck cancer	0.000829	0.0047	CcSEcCtD
Desipramine—Dizziness—Vinblastine—head and neck cancer	0.000829	0.00469	CcSEcCtD
Desipramine—Oedema—Fluorouracil—head and neck cancer	0.000823	0.00466	CcSEcCtD
Desipramine—Asthenia—Hydroxyurea—head and neck cancer	0.00082	0.00464	CcSEcCtD
Desipramine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000805	0.00456	CcSEcCtD
Desipramine—Tachycardia—Fluorouracil—head and neck cancer	0.000803	0.00455	CcSEcCtD
Desipramine—Vomiting—Vinblastine—head and neck cancer	0.000797	0.00451	CcSEcCtD
Desipramine—Headache—Vinblastine—head and neck cancer	0.000785	0.00444	CcSEcCtD
Desipramine—Anorexia—Fluorouracil—head and neck cancer	0.000784	0.00444	CcSEcCtD
Desipramine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000782	0.00443	CcSEcCtD
Desipramine—Flushing—Docetaxel—head and neck cancer	0.000776	0.00439	CcSEcCtD
Desipramine—SLC22A3—thyroid gland—head and neck cancer	0.000775	0.00748	CbGeAlD
Desipramine—Hypotension—Fluorouracil—head and neck cancer	0.000769	0.00435	CcSEcCtD
Desipramine—Dizziness—Hydroxyurea—head and neck cancer	0.000756	0.00428	CcSEcCtD
Desipramine—Arrhythmia—Docetaxel—head and neck cancer	0.000747	0.00423	CcSEcCtD
Desipramine—Nausea—Vinblastine—head and neck cancer	0.000744	0.00421	CcSEcCtD
Desipramine—Insomnia—Fluorouracil—head and neck cancer	0.000744	0.00421	CcSEcCtD
Desipramine—Paraesthesia—Fluorouracil—head and neck cancer	0.000739	0.00418	CcSEcCtD
Desipramine—Alopecia—Docetaxel—head and neck cancer	0.000738	0.00418	CcSEcCtD
Desipramine—CHRM2—head—head and neck cancer	0.000733	0.00707	CbGeAlD
Desipramine—Somnolence—Fluorouracil—head and neck cancer	0.000731	0.00414	CcSEcCtD
Desipramine—SLC6A3—head—head and neck cancer	0.00073	0.00705	CbGeAlD
Desipramine—Vomiting—Hydroxyurea—head and neck cancer	0.000727	0.00411	CcSEcCtD
Desipramine—Dyspepsia—Fluorouracil—head and neck cancer	0.000724	0.0041	CcSEcCtD
Desipramine—Rash—Hydroxyurea—head and neck cancer	0.000721	0.00408	CcSEcCtD
Desipramine—Dermatitis—Hydroxyurea—head and neck cancer	0.00072	0.00408	CcSEcCtD
Desipramine—HRH1—connective tissue—head and neck cancer	0.00072	0.00694	CbGeAlD
Desipramine—SLC22A1—head—head and neck cancer	0.00072	0.00694	CbGeAlD
Desipramine—Headache—Hydroxyurea—head and neck cancer	0.000716	0.00405	CcSEcCtD
Desipramine—Decreased appetite—Fluorouracil—head and neck cancer	0.000715	0.00405	CcSEcCtD
Desipramine—SLC22A5—trachea—head and neck cancer	0.000713	0.00687	CbGeAlD
Desipramine—Dysgeusia—Docetaxel—head and neck cancer	0.000712	0.00403	CcSEcCtD
Desipramine—HTR2C—head—head and neck cancer	0.000706	0.00681	CbGeAlD
Desipramine—ADRB1—head—head and neck cancer	0.000693	0.00668	CbGeAlD
Desipramine—SLC22A3—head—head and neck cancer	0.000688	0.00663	CbGeAlD
Desipramine—HRH1—epithelium—head and neck cancer	0.000683	0.00659	CbGeAlD
Desipramine—Nausea—Hydroxyurea—head and neck cancer	0.000679	0.00384	CcSEcCtD
Desipramine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000678	0.00384	CcSEcCtD
Desipramine—CHRM3—thyroid gland—head and neck cancer	0.000673	0.00649	CbGeAlD
Desipramine—SLC6A4—head—head and neck cancer	0.000669	0.00646	CbGeAlD
Desipramine—CHRM1—head—head and neck cancer	0.000667	0.00643	CbGeAlD
Desipramine—Urticaria—Fluorouracil—head and neck cancer	0.000653	0.0037	CcSEcCtD
Desipramine—Body temperature increased—Fluorouracil—head and neck cancer	0.00065	0.00368	CcSEcCtD
Desipramine—Palpitations—Docetaxel—head and neck cancer	0.000643	0.00364	CcSEcCtD
Desipramine—Convulsion—Docetaxel—head and neck cancer	0.00063	0.00357	CcSEcCtD
Desipramine—Hypertension—Docetaxel—head and neck cancer	0.000628	0.00356	CcSEcCtD
Desipramine—Dry mouth—Docetaxel—head and neck cancer	0.000606	0.00343	CcSEcCtD
Desipramine—HRH1—trachea—head and neck cancer	0.000604	0.00583	CbGeAlD
Desipramine—HTR2A—connective tissue—head and neck cancer	0.000601	0.0058	CbGeAlD
Desipramine—Confusional state—Docetaxel—head and neck cancer	0.000599	0.00339	CcSEcCtD
Desipramine—CHRM3—head—head and neck cancer	0.000597	0.00576	CbGeAlD
Desipramine—HTR1A—head—head and neck cancer	0.000594	0.00573	CbGeAlD
Desipramine—Oedema—Docetaxel—head and neck cancer	0.000594	0.00336	CcSEcCtD
Desipramine—SLC6A2—head—head and neck cancer	0.000589	0.00568	CbGeAlD
Desipramine—Pruritus—Fluorouracil—head and neck cancer	0.000582	0.00329	CcSEcCtD
Desipramine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000581	0.00329	CcSEcCtD
Desipramine—Tachycardia—Docetaxel—head and neck cancer	0.000579	0.00328	CcSEcCtD
Desipramine—HTR2A—epithelium—head and neck cancer	0.000571	0.00551	CbGeAlD
Desipramine—Anorexia—Docetaxel—head and neck cancer	0.000566	0.0032	CcSEcCtD
Desipramine—SLC22A5—thyroid gland—head and neck cancer	0.000564	0.00544	CbGeAlD
Desipramine—Diarrhoea—Fluorouracil—head and neck cancer	0.000563	0.00319	CcSEcCtD
Desipramine—Hypotension—Docetaxel—head and neck cancer	0.000555	0.00314	CcSEcCtD
Desipramine—ORM1—lymph node—head and neck cancer	0.00055	0.00531	CbGeAlD
Desipramine—Dizziness—Fluorouracil—head and neck cancer	0.000544	0.00308	CcSEcCtD
Desipramine—CYP2B6—lymphoid tissue—head and neck cancer	0.000539	0.0052	CbGeAlD
Desipramine—DRD2—head—head and neck cancer	0.000537	0.00518	CbGeAlD
Desipramine—Insomnia—Docetaxel—head and neck cancer	0.000537	0.00304	CcSEcCtD
Desipramine—Paraesthesia—Docetaxel—head and neck cancer	0.000533	0.00302	CcSEcCtD
Desipramine—SLC22A4—lymph node—head and neck cancer	0.000529	0.0051	CbGeAlD
Desipramine—Somnolence—Docetaxel—head and neck cancer	0.000528	0.00299	CcSEcCtD
Desipramine—Vomiting—Fluorouracil—head and neck cancer	0.000523	0.00296	CcSEcCtD
Desipramine—Dyspepsia—Docetaxel—head and neck cancer	0.000523	0.00296	CcSEcCtD
Desipramine—Rash—Fluorouracil—head and neck cancer	0.000519	0.00294	CcSEcCtD
Desipramine—Dermatitis—Fluorouracil—head and neck cancer	0.000518	0.00293	CcSEcCtD
Desipramine—Decreased appetite—Docetaxel—head and neck cancer	0.000516	0.00292	CcSEcCtD
Desipramine—Headache—Fluorouracil—head and neck cancer	0.000515	0.00292	CcSEcCtD
Desipramine—Fatigue—Docetaxel—head and neck cancer	0.000512	0.0029	CcSEcCtD
Desipramine—CYP1A2—thyroid gland—head and neck cancer	0.000511	0.00493	CbGeAlD
Desipramine—Constipation—Docetaxel—head and neck cancer	0.000508	0.00287	CcSEcCtD
Desipramine—CYP2E1—lymphoid tissue—head and neck cancer	0.000506	0.00488	CbGeAlD
Desipramine—HTR2A—trachea—head and neck cancer	0.000505	0.00487	CbGeAlD
Desipramine—Feeling abnormal—Docetaxel—head and neck cancer	0.000489	0.00277	CcSEcCtD
Desipramine—Nausea—Fluorouracil—head and neck cancer	0.000489	0.00277	CcSEcCtD
Desipramine—SLC22A3—lymph node—head and neck cancer	0.000482	0.00464	CbGeAlD
Desipramine—Body temperature increased—Docetaxel—head and neck cancer	0.000469	0.00266	CcSEcCtD
Desipramine—Abdominal pain—Docetaxel—head and neck cancer	0.000469	0.00266	CcSEcCtD
Desipramine—CYP2E1—thyroid gland—head and neck cancer	0.000459	0.00443	CbGeAlD
Desipramine—CYP2B6—head—head and neck cancer	0.000434	0.00419	CbGeAlD
Desipramine—Asthenia—Docetaxel—head and neck cancer	0.000426	0.00241	CcSEcCtD
Desipramine—HRH1—head—head and neck cancer	0.000424	0.00409	CbGeAlD
Desipramine—Pruritus—Docetaxel—head and neck cancer	0.00042	0.00238	CcSEcCtD
Desipramine—SLC6A2—lymph node—head and neck cancer	0.000413	0.00398	CbGeAlD
Desipramine—CYP2E1—head—head and neck cancer	0.000408	0.00393	CbGeAlD
Desipramine—Diarrhoea—Docetaxel—head and neck cancer	0.000406	0.0023	CcSEcCtD
Desipramine—Dizziness—Docetaxel—head and neck cancer	0.000393	0.00222	CcSEcCtD
Desipramine—Vomiting—Docetaxel—head and neck cancer	0.000377	0.00214	CcSEcCtD
Desipramine—Rash—Docetaxel—head and neck cancer	0.000374	0.00212	CcSEcCtD
Desipramine—ABCB1—epithelium—head and neck cancer	0.000374	0.00361	CbGeAlD
Desipramine—Dermatitis—Docetaxel—head and neck cancer	0.000374	0.00212	CcSEcCtD
Desipramine—Headache—Docetaxel—head and neck cancer	0.000372	0.00211	CcSEcCtD
Desipramine—HTR2A—head—head and neck cancer	0.000354	0.00342	CbGeAlD
Desipramine—Nausea—Docetaxel—head and neck cancer	0.000353	0.002	CcSEcCtD
Desipramine—SLC22A5—lymph node—head and neck cancer	0.00035	0.00338	CbGeAlD
Desipramine—ABCB1—trachea—head and neck cancer	0.000331	0.00319	CbGeAlD
Desipramine—CYP2D6—head—head and neck cancer	0.000323	0.00311	CbGeAlD
Desipramine—HRH1—lymph node—head and neck cancer	0.000297	0.00286	CbGeAlD
Desipramine—ABCB1—lymphoid tissue—head and neck cancer	0.000288	0.00278	CbGeAlD
Desipramine—ABCB1—thyroid gland—head and neck cancer	0.000262	0.00252	CbGeAlD
Desipramine—ABCB1—head—head and neck cancer	0.000232	0.00224	CbGeAlD
Desipramine—ABCB1—lymph node—head and neck cancer	0.000163	0.00157	CbGeAlD
Desipramine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	1.7e-05	0.000113	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.68e-05	0.000112	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.68e-05	0.000112	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—AKT1—head and neck cancer	1.68e-05	0.000112	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PTEN—head and neck cancer	1.68e-05	0.000111	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	1.67e-05	0.000111	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	1.67e-05	0.000111	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	1.67e-05	0.000111	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	1.67e-05	0.000111	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	1.67e-05	0.000111	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—MAPK1—head and neck cancer	1.67e-05	0.000111	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—EGFR—head and neck cancer	1.66e-05	0.000111	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.66e-05	0.000111	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—MAPK1—head and neck cancer	1.66e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—EGFR—head and neck cancer	1.66e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTGS2—head and neck cancer	1.65e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—MAPK1—head and neck cancer	1.64e-05	0.000109	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—EGFR—head and neck cancer	1.64e-05	0.000109	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.64e-05	0.000109	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	1.63e-05	0.000108	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.63e-05	0.000108	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—head and neck cancer	1.62e-05	0.000108	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STAT3—head and neck cancer	1.6e-05	0.000107	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.6e-05	0.000106	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.6e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.59e-05	0.000106	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HRAS—head and neck cancer	1.59e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—PIK3CA—head and neck cancer	1.59e-05	0.000106	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	1.58e-05	0.000105	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.57e-05	0.000105	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL2—head and neck cancer	1.56e-05	0.000104	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTEN—head and neck cancer	1.56e-05	0.000104	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	1.56e-05	0.000104	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—head and neck cancer	1.55e-05	0.000103	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	1.55e-05	0.000103	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—head and neck cancer	1.55e-05	0.000103	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—head and neck cancer	1.54e-05	0.000102	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTEN—head and neck cancer	1.54e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STAT3—head and neck cancer	1.54e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MAPK3—head and neck cancer	1.53e-05	0.000102	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL2—head and neck cancer	1.53e-05	0.000102	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CCND1—head and neck cancer	1.53e-05	0.000101	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	1.51e-05	0.000101	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	1.5e-05	0.0001	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TYMS—head and neck cancer	1.5e-05	0.0001	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL2—head and neck cancer	1.5e-05	9.96e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CCND1—head and neck cancer	1.49e-05	9.93e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL2—head and neck cancer	1.49e-05	9.91e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.49e-05	9.89e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.49e-05	9.88e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	1.48e-05	9.83e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PTEN—head and neck cancer	1.47e-05	9.8e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MAPK3—head and neck cancer	1.47e-05	9.77e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	1.46e-05	9.71e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MAPK1—head and neck cancer	1.46e-05	9.71e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—head and neck cancer	1.46e-05	9.71e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—head and neck cancer	1.45e-05	9.68e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.45e-05	9.67e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.45e-05	9.66e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	1.45e-05	9.65e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—PIK3CA—head and neck cancer	1.44e-05	9.62e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTEN—head and neck cancer	1.44e-05	9.6e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—PIK3CA—head and neck cancer	1.44e-05	9.59e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PTEN—head and neck cancer	1.44e-05	9.58e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	1.44e-05	9.56e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	1.43e-05	9.49e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.42e-05	9.47e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.42e-05	9.47e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.41e-05	9.38e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	1.41e-05	9.37e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—head and neck cancer	1.4e-05	9.35e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.4e-05	9.32e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MAPK1—head and neck cancer	1.4e-05	9.3e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—head and neck cancer	1.4e-05	9.3e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.39e-05	9.27e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	1.37e-05	9.14e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.37e-05	9.09e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.37e-05	9.09e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.34e-05	8.94e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.34e-05	8.93e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	1.34e-05	8.9e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	1.33e-05	8.87e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	1.33e-05	8.85e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.33e-05	8.84e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	1.32e-05	8.78e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—head and neck cancer	1.32e-05	8.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL2—head and neck cancer	1.31e-05	8.74e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.31e-05	8.7e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.3e-05	8.68e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—head and neck cancer	1.3e-05	8.66e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	1.3e-05	8.65e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	1.3e-05	8.62e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.29e-05	8.6e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—head and neck cancer	1.29e-05	8.59e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—head and neck cancer	1.29e-05	8.57e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—head and neck cancer	1.29e-05	8.56e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	1.28e-05	8.54e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—head and neck cancer	1.28e-05	8.53e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.28e-05	8.52e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.27e-05	8.46e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—head and neck cancer	1.27e-05	8.45e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—head and neck cancer	1.27e-05	8.42e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.27e-05	8.42e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.26e-05	8.39e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.26e-05	8.38e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	1.26e-05	8.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.26e-05	8.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—head and neck cancer	1.25e-05	8.34e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.25e-05	8.34e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—head and neck cancer	1.25e-05	8.32e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—head and neck cancer	1.24e-05	8.26e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	1.24e-05	8.23e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.24e-05	8.23e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK3—head and neck cancer	1.23e-05	8.19e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—head and neck cancer	1.22e-05	8.15e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.22e-05	8.1e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—head and neck cancer	1.22e-05	8.09e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	8.08e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—head and neck cancer	1.21e-05	8.07e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	8.05e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.21e-05	8.03e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	8.03e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.2e-05	8.01e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.2e-05	7.97e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	1.2e-05	7.96e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—head and neck cancer	1.2e-05	7.96e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	1.19e-05	7.95e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.19e-05	7.9e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	7.88e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	1.18e-05	7.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	7.86e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	7.83e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—head and neck cancer	1.17e-05	7.8e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—head and neck cancer	1.17e-05	7.79e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK1—head and neck cancer	1.17e-05	7.79e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—head and neck cancer	1.17e-05	7.79e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	7.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.16e-05	7.72e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.16e-05	7.7e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.15e-05	7.63e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.14e-05	7.62e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.14e-05	7.62e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.14e-05	7.58e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.14e-05	7.58e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—head and neck cancer	1.12e-05	7.46e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.12e-05	7.43e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.11e-05	7.36e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—head and neck cancer	1.1e-05	7.33e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.1e-05	7.31e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.1e-05	7.31e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.1e-05	7.3e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	7.27e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	7.25e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.09e-05	7.24e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.09e-05	7.24e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.09e-05	7.22e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.08e-05	7.22e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	7.2e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	1.08e-05	7.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	7.18e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.08e-05	7.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	1.07e-05	7.11e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.06e-05	7.03e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.05e-05	6.98e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.04e-05	6.92e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	1.04e-05	6.91e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.04e-05	6.9e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—head and neck cancer	1.03e-05	6.88e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	6.88e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	6.86e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	1.02e-05	6.79e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—head and neck cancer	1.02e-05	6.77e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—head and neck cancer	1.02e-05	6.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.01e-05	6.69e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—head and neck cancer	1e-05	6.69e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—head and neck cancer	1e-05	6.69e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	9.93e-06	6.61e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—head and neck cancer	9.9e-06	6.59e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	9.89e-06	6.58e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—head and neck cancer	9.89e-06	6.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	9.89e-06	6.58e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	9.88e-06	6.58e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	9.87e-06	6.57e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—head and neck cancer	9.87e-06	6.57e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	9.84e-06	6.55e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	9.83e-06	6.54e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—head and neck cancer	9.83e-06	6.54e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	9.81e-06	6.53e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—head and neck cancer	9.8e-06	6.52e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	9.71e-06	6.46e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	9.71e-06	6.46e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—head and neck cancer	9.65e-06	6.43e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—head and neck cancer	9.61e-06	6.4e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—head and neck cancer	9.61e-06	6.39e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—head and neck cancer	9.56e-06	6.36e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—head and neck cancer	9.4e-06	6.25e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—head and neck cancer	9.38e-06	6.24e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	9.19e-06	6.12e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—head and neck cancer	9.15e-06	6.09e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	9.14e-06	6.08e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—head and neck cancer	9e-06	5.99e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—head and neck cancer	8.86e-06	5.9e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	8.75e-06	5.83e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	8.72e-06	5.8e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—head and neck cancer	8.62e-06	5.74e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	8.58e-06	5.71e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	8.57e-06	5.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	8.56e-06	5.7e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	8.54e-06	5.68e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	8.51e-06	5.66e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—head and neck cancer	8.48e-06	5.65e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—head and neck cancer	8.44e-06	5.61e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	8.43e-06	5.61e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—head and neck cancer	8.38e-06	5.58e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—head and neck cancer	8.31e-06	5.53e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—head and neck cancer	8.3e-06	5.52e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—head and neck cancer	8.3e-06	5.52e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—head and neck cancer	8.28e-06	5.51e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—head and neck cancer	8.26e-06	5.5e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—head and neck cancer	8.23e-06	5.48e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—head and neck cancer	8.15e-06	5.42e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	8.11e-06	5.4e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	8.07e-06	5.37e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—head and neck cancer	8.07e-06	5.37e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	7.94e-06	5.28e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—head and neck cancer	7.92e-06	5.27e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	7.9e-06	5.26e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—head and neck cancer	7.87e-06	5.24e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	7.8e-06	5.19e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—head and neck cancer	7.31e-06	4.86e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—head and neck cancer	7.15e-06	4.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—head and neck cancer	7.12e-06	4.74e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	7.01e-06	4.67e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—head and neck cancer	7e-06	4.66e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—head and neck cancer	7e-06	4.66e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	6.97e-06	4.64e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—head and neck cancer	6.95e-06	4.63e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	6.88e-06	4.58e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	6.61e-06	4.4e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.47e-06	4.3e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.46e-06	4.3e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.08e-06	4.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—head and neck cancer	5.64e-06	3.75e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—head and neck cancer	5.4e-06	3.6e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—head and neck cancer	5.27e-06	3.51e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.15e-06	3.43e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—head and neck cancer	4.97e-06	3.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—head and neck cancer	4.21e-06	2.8e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.98e-06	2.65e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.25e-06	2.16e-05	CbGpPWpGaD
